Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Nov 10, 2009


Christopher Sears, chief scientific officer of Ambergen, has joined the scientific advisory board of WaferGen. Previously, he held joint academic appointments in the field of oncology at Children's Hospital Boston, the Broad Institute, Harvard Medical School, and the Dana Farber Cancer Institute, where he was responsible for directing projects and operations of the clinical genomics group. He has also served as a scientific advisor for the Department of Justice and the Federal Bureau of Investigation in the areas of genetics and statistics for the development of high-throughput comparative forensics genomic technologies. Sears holds a doctorate in biochemistry and molecular and cellular biology from Harvard University.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.